A three-judge panel on the 5th U.S. Circuit Court of Appeals sided with Louisiana in a lawsuit against the Food and Drug Administration (FDA). The court issued a temporary nationwide injunction that reinstates a 2021 nationwide requirement that mifepristone must be prescribed and dispensed in person.
Mifepristone is one of the two drugs commonly used in medication abortions.
The FDA permanently lifted the in-person requirement in 2023, leading to a surge in pills prescribed over the internet in the wake of the Dobbs ruling that overturned the constitutional right to an abortion.
A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges...
When Bug got home from school one winter afternoon in late 2024, his mother was on...
A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while...
Donald Trump has selected Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC),...
